Rehmann Capital Advisory Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.44M Sell
38,637
-3,676
-9% -$856K 0.49% 36
2025
Q4
$8.76M Buy
42,313
+2,924
+7% +$578K 0.46% 41
2025
Q3
$7.29M Sell
39,389
-598
-1% -$102K 0.4% 46
2025
Q2
$6.11M Sell
39,987
-1,129
-3% -$174K 0.37% 51
2025
Q1
$6.82M Sell
41,116
-3,081
-7% -$482K 0.43% 45
2024
Q4
$6.39M Buy
44,197
+572
+1% +$88.6K 0.41% 53
2024
Q3
$7.09M Sell
43,625
-1,728
-4% -$275K 0.46% 41
2024
Q2
$6.63M Buy
45,353
+3,831
+9% +$570K 0.48% 37
2024
Q1
$6.57M Sell
41,522
-977
-2% -$156K 0.49% 35
2023
Q4
$6.66M Sell
42,499
-913
-2% -$140K 0.55% 33
2023
Q3
$6.76M Sell
43,412
-992
-2% -$164K 0.63% 32
2023
Q2
$7.35M Sell
44,404
-312
-0.7% -$50.4K 0.66% 30
2023
Q1
$6.93M Sell
44,716
-349
-0.8% -$56.4K 0.65% 31
2022
Q4
$7.96M Sell
45,065
-1,335
-3% -$231K 0.82% 25
2022
Q3
$7.58M Buy
46,400
+3,357
+8% +$568K 0.84% 23
2022
Q2
$7.64M Sell
43,043
-595
-1% -$106K 0.84% 23
2022
Q1
$7.73M Buy
43,638
+593
+1% +$101K 0.73% 29
2021
Q4
$7.36M Buy
43,045
+1,348
+3% +$221K 0.68% 26
2021
Q3
$6.75M Buy
41,697
+1,001
+2% +$171K 0.64% 28
2021
Q2
$6.71M Buy
40,696
+515
+1% +$85.3K 0.65% 25
2021
Q1
$6.6M Buy
40,181
+472
+1% +$76.4K 0.68% 25
2020
Q4
$6.25M Buy
39,709
+4,784
+14% +$706K 0.71% 25
2020
Q3
$5.2M Buy
34,925
+55
+0.2% +$8.14K 0.66% 27
2020
Q2
$4.9M Buy
34,870
+868
+3% +$126K 0.67% 26
2020
Q1
$4.46M Buy
+34,002
New +$4.82M 0.73% 25
2019
Q3
$4.59M Buy
35,488
+971
+3% +$128K 0.56% 22
2019
Q2
$4.81M Buy
34,517
+678
+2% +$93.8K 0.59% 32
2019
Q1
$4.73M Sell
33,839
-1,557
-4% -$209K 0.64% 29
2018
Q4
$4.57M Sell
35,396
-195
-0.5% -$27.2K 0.69% 20
2018
Q3
$4.92M Buy
35,591
+256
+0.7% +$34K 0.68% 27
2018
Q2
$4.29M Sell
35,335
-969
-3% -$121K 0.62% 30
2018
Q1
$4.65M Buy
36,304
+3,275
+10% +$443K 0.72% 25
2017
Q4
$4.62M Sell
33,029
-1,310
-4% -$182K 0.78% 24
2017
Q3
$4.46M Buy
34,339
+496
+1% +$65.8K 0.8% 23
2017
Q2
$4.48M Sell
33,843
-5,354
-14% -$683K 0.86% 23
2017
Q1
$4.88M Buy
39,197
+1,773
+5% +$212K 0.81% 26
2016
Q4
$4.31M Buy
37,424
+3,520
+10% +$407K 0.79% 27
2016
Q3
$4M Sell
33,904
-4,790
-12% -$581K 0.78% 29
2016
Q2
$4.69M Buy
38,694
+88
+0.2% +$10K 0.88% 25
2016
Q1
$4.18M Buy
38,606
+9,725
+34% +$1.01M 0.81% 26
2015
Q4
$2.97M Buy
28,881
+362
+1% +$36.4K 0.62% 36
2015
Q3
$2.66M Buy
28,519
+837
+3% +$81K 0.6% 38
2015
Q2
$2.7M Sell
27,682
-82
-0.3% -$8.21K 0.62% 35
2015
Q1
$2.79M Sell
27,764
-366
-1% -$37.2K 0.63% 35
2014
Q4
$2.94M Buy
28,130
+24
+0.1% +$2.53K 0.68% 33
2014
Q3
$3M Buy
28,106
+492
+2% +$51K 0.71% 33
2014
Q2
$2.89M Buy
27,614
+346
+1% +$35K 0.69% 34
2014
Q1
$2.68M Sell
27,268
-590
-2% -$54.7K 0.72% 29
2013
Q4
$2.55M Buy
27,858
+444
+2% +$40.9K 0.77% 31
2013
Q3
$2.38M Buy
27,414
+1,183
+5% +$106K 0.77% 30
2013
Q2
$2.25M Buy
+26,231
New +$2.23M 0.78% 29

Other funds holding JNJ

Rehmann Capital Advisory Group's JNJ Position: Q1 2026 in Review

Rehmann Capital Advisory Group reduced its Johnson & Johnson (JNJ) stake by 8.7% in Q1 2026, selling an estimated $856K and leaving 38,637 shares worth $9.44M. The position accounts for 0.49% of the portfolio, ranked #36.

Rehmann Capital Advisory Group first reported a position in JNJ in Q2 2013 and has held it in 51 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Rehmann Capital Advisory Group held 38,637 shares of Johnson & Johnson worth $9.44M as of Q1 2026.
  • Rehmann Capital Advisory Group sold 3,676 Johnson & Johnson shares in Q1 2026, an estimated $856K.
  • Johnson & Johnson made up 0.49% of Rehmann Capital Advisory Group's portfolio in Q1 2026, its #36 holding.
  • Rehmann Capital Advisory Group first reported a position in Johnson & Johnson in Q2 2013 and has held it in 51 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Rehmann Capital Advisory Group's 13F filing for Q1 2026, filed 15 May 2026.